This review focuses on summarizing key biological functions of the PRMT5–SND1 reader–writer pair (Figure 2), then surveys what is known about these proteins as they relate to HCC, and concludes with speculation on unexplored avenues of therapeutic modulation of methylarginine levels in HCC as a potential form of treatment. The gene discussed is SND1; the disease is hepatocellular carcinoma.